Live from the NIH registry
Studies recruiting near Albany right now
Top 25 of 197 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Phase 2
Interventional 465 participants sought
Albany Medical College — Albany, New York (2.4 mi)
· Sponsor: Novo Nordisk A/S
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Alzheimer Disease
Phase 4
Interventional 150 participants sought
Alzheimer's Disease Research Center — Albany, New York (2.4 mi)
· Sponsor: Alpha Cognition, Inc
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
Transitional Cell Cancer of Renal Pelvis and Ureter
Phase 3
Interventional 100 participants sought
Albany Medical College — Albany, New York (2.4 mi)
· Sponsor: Steba Biotech S.A.
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
N/A
Interventional 600 participants sought
Albany Medical College — Albany, New York (2.4 mi)
· Sponsor: Medtronic Cardiovascular
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
Cesarean Delivery, General Anesthesia
N/A
Observational 5,000 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Yale University
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Ulcerative Colitis (UC)
Phase 1, Phase 2
Interventional 270 participants sought
Xencor Investigative Site — Albany, New York (2.4 mi)
· Sponsor: Xencor, Inc.
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Albany, New York (2.4 mi)
· Sponsor: Sameek Roychowdhury
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Multiple Myeloma, Secondary Immunodeficiency
Phase 3
Interventional 183 participants sought
New York Oncology Hematology — Albany, New York (2.4 mi)
· Sponsor: Takeda
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Obesity, Overweight
Phase 3
Interventional 1,100 participants sought
ACCOMPLISH-2 Research Site — Albany, New York (2.4 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
Neurogenic Detrusor Overactivity
Phase 2, Phase 3
Interventional 71 participants sought
Albany Medical College — Albany, New York (2.4 mi)
· Sponsor: Urovant Sciences GmbH
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
Capital Cardiology Associates — Albany, New York (2.4 mi)
· Sponsor: Amgen
A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)
Short Bowel Syndrome (SBS), SBS Associated With Intestinal Failure (SBS-IF)
Phase 3
Interventional 124 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: VectivBio AG
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
B Acute Lymphoblastic Leukemia Associated With Down Syndrome, Down Syndrome
N/A
Observational 330 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Children's Oncology Group
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Asthma
Phase 3
Interventional 231 participants sought
Research Site — Schenectady, New York (12.5 mi)
· Sponsor: AstraZeneca
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Albany Medical College- Endocrinology Washington Extension /ID# 256794 — Albany, New York (2.4 mi)
· Sponsor: AbbVie
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Colon Adenocarcinoma, Rectal Adenocarcinoma
Phase 3
Interventional 477 participants sought
Ellis Hospital ( Site 0098) — Schenectady, New York (12.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
New York Oncology Hematology — Albany, New York (2.4 mi)
· Sponsor: Pfizer
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
C3G
Phase 3
Interventional 98 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Albany, New York (2.4 mi)
· Sponsor: 89bio, Inc.
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Albany MED Health System — Albany, New York (2.4 mi)
· Sponsor: Pacific Edge Limited
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 630 participants sought
Ellis Hospital — Schenectady, New York (12.5 mi)
· Sponsor: Mirati Therapeutics Inc.
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 3
Interventional 700 participants sought
New York Oncology Hematology — Albany, New York (2.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Children's Oncology Group